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CPR cardiopulmonary resuscitation 
CT computed tomography 
ECLS extracorporeal life support 
ECMO extracorporeal membrane oxygenation 
ICU  intensive care unit 
PA pulmonary artery 
PE pulmonary embolism 
RV right ventricle 
tPA tissue plasminogen activator 
VA ECMO veno-arterial extracorporeal membrane oxygenation 
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Introduction 
Cardiogenic shock that results from pulmonary embolus has a high mortality rate. 
Systemic thrombolysis is frequently used in submassive and massive pulmonary 
embolus and has been shown to restore circulation. However, in the event of 
impending or ongoing cardiac arrest, systemic thrombolysis or anticoagulation 
alone has not been always shown to be effective. Case reports have previously 
established that extracorporeal membrane oxygenation can effectively be used 
as an effective rescue strategy in cases of cardiac arrest as a result from 
massive pulmonary embolus. We report six cases of massive pulmonary 
embolism (PE), in which veno-arterial extracorporeal membrane oxygenation (VA 
ECMO) was utilized or used as a backup strategy with excellent outcomes. We 
highly recommend using this strategy at the bedside in a tertiary care facility 
where VA ECMO support is available. 
Methods 
 This is a retrospective study of all patients that underwent VA ECMO or utilized 
VA ECMO at the bedside as a rescue strategy in the setting of massive PE. We 
abstracted relevant clinical information from patient charts for this review. 
Results and analysis 
 Out of the 107 VA ECMO runs performed at our facility between 1 September 
2013 and 31 December 2014, four patients utilized this strategy in the setting of 
massive PE with impending cardiac arrest; in two cases it was available to use 
as a backup strategy. All six patients (Table 1) had successful recovery with 
complete restoration of cognitive status, functional status, and without any clinical 
signs of right ventricular (RV) dysfunction on discharge. 
Case 1 
 
We report a case of a 75-year-old African American woman with previous history 
of hypertension that presented to our hospital six weeks prior to the current 
admission with symptoms of left sided weakness and was found to have a 
subdural hematoma. Patient underwent subdural hematoma evacuation and was 
found to have a mass in the right parietal area that was completely resected and 
was given the diagnosis of “Diffuse Large B Cell Lymphoma.” She was 
subsequently seen by neuro-oncology and was initiated on methotrexate, folinic 
acid, and rituximab. She had been doing well at home, was walking for two miles 
a day, and performing activities of daily living prior to the presentation. Two days 
after her second cycle of chemotherapy with methotrexate and rituximab, patient 
was noted to have dizziness and hypotension and was admitted to the intensive 
care unit (ICU) for further monitoring.  In the ICU, patient was noted to have 
progressive hypotension and she underwent a computed tomography (CT) PE 
study that revealed filling defects within right and left pulmonary arteries (PAs). 
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An echocardiogram confirmed severe RV dysfunction. Given her recent 
craniotomy less than six weeks prior to the current presentation, systemic 
thrombolytics were not a viable option. Patient was emergently taken to the 
interventional suite for a catheter-directed thrombectomy with utilization of VA 
ECMO. In the interventional suite, patient emergently underwent cannulation 
because of severe hypotension, bradycardia and impending cardiac arrest. 
During this time, patient was given moderate sedation and a decision was made 
not to intubate given potential cardiovascular collapse with induction. Once 
stabilized on VA ECMO with a flow of two liters per minute at 2800 revolutions 
per minute, patient was able to talk and hemodynamics normalized. She 
subsequently underwent catheter-directed thrombectomy using AngioJet. Patient 
was then taken to the ICU and monitored for forty-eight hours on full 
anticoagulation with bivalirudin. On post-ECMO day 4, a repeat echocardiogram 
and CT Chest scan revealed decreased clot burden and RV strain. The ECMO 
was successfully decannulated and patient was monitored in ICU for twenty-four 
hours. She also underwent an inferior vena cava filter placement prior to transfer 
from the intensive care unit. She was subsequently discharged home one week 
later on warfarin. She was seen at one month, two month and six months follow-
up and she reported excellent functional status. Her RV strain had significant 
improved from severe to mild at the time of the six-month visit. 
 
Case 2 
 
 A 69-year-old Caucasian woman with past medical history of hypertension, 
hypothyroidism, and breast cancer status post bilateral mastectomy was doing 
well and presented after an accidental fall. She sustained multiple upper limb 
fractures and underwent serial surgeries over the course of a week. After the 
third surgery at an outside hospital, she was noted to be hypotensive, hypoxic 
and had a cardiac arrest. No thrombolytics were offered at the outside hospital 
given the recent surgery. During the resuscitation, our team was called and VA 
ECMO was emergently placed to stabilize the patient. Prior to the ECMO, she 
was on high dose levophed, vasopressin and dopamine. After the ECMO was 
placed, the pressors were weaned at our facility and CT PE protocol revealed 
extensive bilateral PE with an echocardiogram that revealed severe RV 
dysfunction. When patient’s RV strain had not improved after systemic 
thrombolytics, the decision was made to proceed to surgical thrombectomy, and 
patient had a successful pulmonary endarectomy five days after presentation. 
During the procedure, she had a cardiopulmonary bypass time of sixty minutes. 
She was subsequently monitored in the ICU and was closely monitored for 
hemodynamic compromise. Explantation of the VA ECMO was done successfully 
within twenty-four hours of the pulmonary embolectomy. Patient remained 
hemodynamically stable and was weaned off sedation and subsequently 
extubated four days after the VA ECMO decannulation. She had an uneventful 
post-operative course and was discharged home. At nine-month follow-up, she 
had a normal echocardiogram and continues to live a healthy normal life.  
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Case 3 
 
A 69-year-old gentleman with history of hypertension and diabetes mellitus was 
admitted to an outside hospital with generalized weakness and was found to 
have metabolic encephalopathy, diabetic ketoacidosis, and acute kidney injury. 
He was treated there appropriately for diabetic ketoacidosis and was discharged 
four days after admission. Prior to discharge, he had a right internal jugular 
central line removed. Patient notes that by the evening of the discharge, he had 
worsening dyspnea and presented to our emergency department with relative 
hypotension, tachycardia and dyspnea without hypoxia. He underwent imaging 
that revealed a saddle pulmonary embolus (Figure 1) and was admitted to the 
medical intensive care unit for further care. His laboratory investigations were 
unremarkable except for thrombocytopenia (75k). An echocardiogram revealed 
severe RV dysfunction with a thrombus in transit (Figure 2). Patient was 
subsequently noted to be hypotensive, but given the thrombocytopenia, 
thrombolytics were thought to be a relative contraindication. Additionally, 
interventional radiology refused the patient due to his unstable hemodynamic 
status. After discussion with the perfusion service, a VA ECMO was available in 
the interventional radiology suite in case of decompensation. Arterial and venous 
access was secured for potential ECMO prior to the initiation of catheter-directed 
embolectomy. Post extraction venography demonstrated no significant residual 
clot. Patient was subsequently transferred to the ICU and monitored for 24 hours. 
He was transitioned to warfarin and was discharged home once the INR 
achieved therapeutic range. He has followed up in our center for eight months 
without resulting hemodynamic consequences and displaying normal 
echocardiography.  
 
Case 4  
 
A 48-year-old man presented to an outside hospital with gradually worsening 
dyspnea on exertion over a period of three weeks. He was evaluated in the 
emergency center and was found to have dilated right heart chambers on 
bedside echocardiography. He was noted to be tachycardic with a heart rate at 
120 beats per minute and normotensive on arrival, and a CT scan of the chest 
revealed bilateral occlusive thrombus in the right and left main PAs. He was 
planned to receive systemic thrombolysis, but suffered a cardiopulmonary arrest 
(pulseless electrical activity). He underwent about 45 minutes of cardiopulmonary 
resuscitation (CPR) in total, during which the thrombolytic (alteplase) was 
administered and endotracheal intubation was performed, with brief return of 
spontaneous circulation intermittently. Since he was neurologically intact 
between episodes of CPR, ECMO services were called in emergently for 
cardiopulmonary stabilization, and he was initiated on hypothermia protocol for 
neuroprotection after instituting VA ECMO (femoral to femoral). Following this, he 
was taken to the interventional radiology suite for concerning residual pulmonary 
embolus post-alteplase administration and for mechanical thrombectomy. 
Suction thrombectomy using an AngioJet was performed within the right PA and 
following multiple passes, the majority of the clot within the right main PA was 
successfully removed. There was markedly improved perfusion of the right lung 
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after this. Patient was monitored in the ICU and decannulated seventy-two hours 
after the VA ECMO cannulation. He was extubated within twenty-four hours after 
decannulation. Patient was followed up in clinic without any further issues from 
PE. 
 
 
  
 
 
Figure 1: A representative computed tomography image of saddle 
pulmonary embolus and occlusive embolus in the right main pulmonary 
trunk. 
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Figure 2: Two-dimensional echocardiogram displaying large echodensities 
within right-sided heart chambers consistent with thrombus in transit. 
 
 
Case 5 
 
A 50-year-old previously healthy female was brought to an outside hospital after 
sustaining cardiac arrest.  She had a history of prolonged travel the week prior 
and was noted to be diaphoretic, pale, and pulseless on the airplane. She was 
resuscitated and brought to an outside hospital when our team was called to 
place an emergent VA ECMO. The CT angiogram showed extensive massive PE 
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and patient had forty-five minutes of CPR. An echocardiogram revealed severe 
RV dysfunction. She was air lifted to our facility after cannulation by our team 
with CPR in progress. She went to the operative suite for an emergent 
embolectomy. Upon return from the operative suite, we weaned all the pressors 
and the VA ECMO was removed on post-operative day three. She was extubated 
on post-operative day six. Patient was managed on bivalirudin and bridged to 
Coumadin. She was fully functional without any evidence of RV dysfunction upon 
discharge home. She is being followed up by the local pulmonologist at her 
hometown. 
 
Case 6 
 
A 61-year-old gentleman presented to outside hospital with past medical history 
of prostate cancer status post radiation, meningioma status post resection with 
craniotomy in 2000 and again eight months prior to current admission. He 
displayed exertional angina, and unilateral lower extremity edema in the right leg. 
On presentation, patient was hemodynamically unstable and was found to have a 
large saddle pulmonary embolism with bilateral thrombi, and patient was 
maintained on norepinephrine. An echocardiogram confirmed significant RV 
strain and patient was emergently transferred to our facility. After risks and 
benefits were discussed with the patient, with perfusion service as backup, 
patient underwent placement of EKOS catheter into the right and left main 
pulmonary arteries. A conservative dose of tissue plasminogen activator (tPA) 
was chosen because of meningioma surgery and a dose of 0.5 mg per hour were 
given for twenty-four hours along with fixed dose heparin at 500 units per hour.  
EKOS catheters were removed at the bedside on the second day and patient 
was switched to bivalirudin for increased clot burden detected on repeat CT 
angiogram. Six days later, patient was taken back to the cath lab for AngioJet 6-
French system to lyse the clot further. He tolerated the successful debulking of 
the saddle embolus and was subsequently switched to warfarin and discharged 
home. 
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Table 1. Brief clinical summaries for each patient case 
 
 Presentation Treatment strategy Outcome 
Case 1 75-year-old African 
American woman admitted 
to ICU and noted to have 
progressive hypotension. 
CT PE and 
echocardiogram revealed 
RV dysfunction. 
Cannulation of VA ECMO in 
interventional suite due to severe 
hypotension, bradycardia and 
impending cardiac arrest. Patient 
was not intubated given potential 
cardiovascular collapse. She 
underwent catheter-directed 
thrombectomy using AngioJet. 
CT PE and echocardiogram on 
post-ECMO day 4 showed 
decreased clot burden and RV 
strain. Follow up visits show 
marked improvement in RV 
strain from severe to mild. 
Case 2 69-year-old Caucasian 
lady was referred by 
outside hospital during 
resuscitation after surgery 
from accidental upper limb 
injury. CT PE and 
echocardiogram revealed 
extensive bilateral PE and 
RV dysfunction. Patient 
was on high dose 
norepinephrine, 
vasopressin, dopamine. 
VA ECMO emergently placed and 
vasopressors weaned. Systemic 
thrombolytics did not work, so she 
underwent surgical thrombectomy 
(bypass time 60 min). 
VA ECMO explanted within 24 
hr of embolectomy. Patient 
weaned off sedation and 
subsequently extubated four 
days after decannulation. Nine-
month follow-up visits 
showcase normal 
echocardiogram. 
Case 3 69-year old gentleman 
admitted to emergency 
room with relative 
hypotension, tachycardia 
and dyspnea without 
hypoxia. He had been 
discharged the same day 
following treatment for 
diabetic ketoacidosis. 
Studies revealed a saddle 
pulmonary embolus and 
thrombocytopenia (75k). 
Echocardiogram revealed 
severe RV dysfunction 
with thrombus in transit. 
Use of thrombolytics discarded due 
to thrombocytopenia. VA ECMO 
access was secured in 
interventional radiology suite in 
case of decompensation, but was 
not used. 
Post-extraction venography 
demonstrated no significant 
residual clot. ICU monitoring for 
24 hours and transitioned to 
Coumadin for INR stabilization. 
Eight months without resulting 
hemodynamic consequence 
and normal echocardiography. 
Case 4 48-year-old normotensive 
male presented with 
tachycardia. CT Chest 
revealed bilateral occlusive 
thrombus in right and left 
main PAs. 
Planned to receive systemic 
thrombolysis, but suffered 
cardiopulmonary arrest. He 
underwent CPR for 45 min, was 
administered thrombolytic alteplase, 
and intubated. Following 
neurological assessment, patient 
was put on VA ECMO and 
underwent successful mechanical 
72 hr after VA ECMO 
cannulation, patient was 
explanted and in follow-up 
visits in clinic showed no issues 
from the PE. 
 
 
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2015.17 Page 9 of 14 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
suction thrombectomy using 
AngioJet. 
Case 5 50-year-old female 
sustaining cardiac arrest 
referred by outside 
hospital where she was 
noted to be diaphoretic, 
pale, and pulseless. CT 
angiogram showed 
massive EP and 
underwent 45 min CPR. 
Her echocardiogram 
revealed severe RV 
dysfunction. 
VA ECMO was placed on patient 
and she was air lifted with CPR in 
progress to our facility. Here, she 
underwent emergent surgical 
embolectomy. 
Pressors were weaned and VA 
ECMO explanted three days 
after operation. She was fully 
functional without evidence of 
RV dysfunction upon 
discharge. 
Case 6 61-year old man with 
history of prostate cancer. 
Saddle pulmonary 
embolism with bilateral 
thrombi maintained on 
norepinephrine 
Echocardiogram confirmed 
significant RV strain and 
emergently transferred to 
our facility. 
Conservative tPA doses (0.5 mg/hr)  
and heparin drip (500 U/hr) were 
used due to past meningioma 
surgery. EKOS catheters placed 
into right and left main PAs. 
Bivalirudin was started on the 
second day due to increased clot 
burden revealed on CT angiogram. 
Six days later, patient underwent 
AngioJet intervention to lyse clot 
further. 
Patient tolerated debulking of 
saddle embolus, switched from 
bivalirudin to warfarin, and 
discharged home. 
 
Discussion 
 
The manifestations of acute PE may range from being asymptomatic to sudden 
death. Current management practices mandate early diagnosis and risk 
stratification, which includes evaluation of hemodynamic parameters and of 
cardiac function/impairment with a 2D echocardiogram, and biomarkers of 
cardiac injury. Life threatening acute PE results from the interaction of clot 
burden and underlying cardiopulmonary status, resulting in hemodynamic 
instability.5 Mortality from cardiogenic shock following massive PE approaches 
75%.2 Massive PE is defined as acute PE with sustained hypotension (systolic 
blood pressure < 90 mmHg for at least 15 minutes or requiring inotropic support, 
not due to a cause other than PE, such as arrhythmia, hypovolemia, sepsis, or 
left ventricular dysfunction), pulselessness, or persistent profound bradycardia 
(heart rate < 40 bpm with signs or symptoms of shock).6 The pathophysiology of 
massive PE consists of direct mechanical obstruction in the pulmonary arterial 
system, hypoxic vasoconstriction that increases pulmonary vascular resistance 
and RV afterload. Acute RV pressure overload may then result in RV hypokinesis 
and dilatation, tricuspid regurgitation, and ultimately RV failure. This presentation 
in extremis is not uncommon, and such patients are often too unstable to 
undergo definite management of the embolus, either successful thrombolysis 
and/or embolectomy. Thrombolysis in these patients should not be delayed 
because irreversible cardiogenic shock may ensue.7 Management of massive PE 
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causing hemodynamic instability is challenging especially in the setting of 
contraindications to systemic thrombolysis, as in three of the patients described 
here. Even when patients with acute massive PE are prescreened for absolute 
contraindications, the rate of major hemorrhage from systemic thrombolytic 
administration is approximately 20%, including a 3% to 5% risk of hemorrhagic 
stroke.8 Other modalities of treatment include catheter-directed or surgical 
embolectomy. 
In a systematic review of available cohort data comprising a total of 348 patients, 
clinical success with percutaneous therapy alone for patients with acute massive 
PE was 81% (aspiration thrombectomy 81%; fragmentation 82%; rheolytic 
thrombectomy 75%) and was 95% when combined with local infusion of 
thrombolytic agents (aspiration thrombectomy 100%; fragmentation 90%; 
rheolytic thrombectomy 91%).13  
Recommendations for Catheter-Based Treatment for Massive PE (adapted 
from reference 8) 
1. Depending on local expertise, either catheter embolectomy and 
fragmentation or surgical embolectomy is reasonable for patients with 
massive PE and contraindications to fibrinolysis (Class IIa; Level of evidence 
C ). 
2. Catheter embolectomy and fragmentation or surgical embolectomy is 
reasonable for patients with massive PE who remain unstable after receiving 
fibrinolysis (Class IIa; Level of Evidence C). 
Surgical embolectomy has historically had a high mortality rate—between 20% to 
30%.14 Leacche et al.[15] reported a 6% mortality rate (3 out of 47 patients) in 
patients with massive PE who underwent a surgical embolectomy. However in 
this series, hemodynamic instability was noted only in 26% of the patients. A 
significantly higher mortality, up to 70%, has been reported in patients who 
undergo cardiopulmonary resuscitation.[16] The best surgical candidates are those 
patients with a large amount of clot limited to the central main PA. The decision 
to proceed with catheter-based versus surgical embolectomy requires 
coordinated teamwork involving the intensivist, interventional radiologist, and the 
thoracic surgeon. 
In hemodynamically unstable patients, prompt surgical intervention with ECMO 
can be life-saving. In acute massive PE, use of extracorporeal life support 
(ECLS) was first reported in 1961.[3] VA ECMO support provides cardiac and 
respiratory support as it helps maintain blood flow with the help of centrifugal 
roller pumps and oxygenated venous blood through a membrane oxygenator. In 
addition, it corrects the resulting acidosis from respiratory failure. This 
hemodynamic stabilization restores organ perfusion and allows time to enable 
definitive management of PE—surgical or catheter-directed embolectomy. This is 
especially helpful in emergent situations in which the femoral vein and the artery 
can be easily cannulated, even in the presence of ongoing CPR. At our center, 
we believe that facilitated thrombolysis utilizing VA ECMO support offers “RV 
rest” and thereby rescues the patient in the setting of cardiac arrest. In these 
cases, utilizing thrombolytics without appropriate resuscitation of circulatory 
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arrest may not be fruitful, and utilizing VA ECMO will establish the circulatory 
support so that facilitated thrombolysis may be subsequently more effective. In all 
of the presented cases, we were able to decompress the acutely overloaded RV, 
allowing us time to undertake a definitive management choice. 
When we were able to bypass the “obstruction” to the RV with ECLS, 
hemodynamic parameters improved and vasopressor requirements diminished 
resulting in improved end organ perfusion, as evidenced by lactate clearance. 
Following definitive treatment of the PE with the relief of the obstruction and 
restoring forward flow from the RV, all patients underwent successful 
decannulation of the ECMO circuit with subsequent improvement in RV function. 
Maggio et al.4 reported a series of 21 patients with pulmonary embolism requiring 
ECLS, with a survival rate of 62%. The mean duration of ECLS was 4.7 days; 
however, 10 of the 13 survivors did not receive additional therapy other than 
anticoagulation. This was based on their observation that the clot typically 
undergoes significant autolysis in about 5 days. We add to this data and report 
one hundred percent survival utilizing this strategy.   
We hereby report a series of six patients with massive PE out of which four who 
underwent initial stabilization with VA ECMO and subsequently underwent 
thrombectomy (3 catheter-directed and 1 surgical) with a 100% survival to 
discharge. The choice of therapy for massive PE—thrombolytics, clot 
fragmentation, catheter embolectomy or surgical embolectomy—depends on the 
expertise available at each institution. Currently, there are no randomized trials 
addressing superiority of one therapy over the other. Although ECMO appears as 
an attractive approach, potential drawbacks of using ECMO in this particular 
setting should be kept in mind. These may include vascular injury during 
cannulation, bleeding complications, and dislodging additional clots from the 
inferior vena cava, none of which were seen in our cases. In addition, there may 
be significant costs involved with instituting ECMO in patients who would have 
done well with systemic thrombolysis. ECLS should be considered in patients 
who are otherwise good candidates for systemic thrombolytics but who continue 
to be in persistent shock despite administration of thrombolytics. It should 
definitely be considered in patients with cardiopulmonary arrest due to a 
pulmonary embolus.  
We also prefer using direct thrombin inhibitors (bivalirudin) in patients with 
significantly elevated clot burden.  Bivalirudin, a direct thrombin inhibitor with 
short half-life, reliable anticoagulant response, and a capacity to reduce the 
thrombogenic potential of thrombin bound to clot is likely a better agent than 
heparin in patients with mechanical circulatory support devices. Previous studies 
utilizing bivalirudin in implantable ventricular assist devices as a first line agent 
have shown that there is no incidence of thromboembolic complications, which is 
similar to our experience. In one study, patients that have been on bivalirudin in 
the setting of post-cardiotomy shock, bivaliruidin has been found to have a less 
bleeding and less transfusion requirements, along with reduced costs. Large 
scale studies need to be done to show the cost benefit analysis of bivalirudin as 
a first line agent  when compared to heparin.17 
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We also recommend management of these patients by a multidisciplinary team 
who are able to arrive to the bedside in a timely manner similar to the STEMI 
pager system utilized nationwide. We recommend an algorithm (Figure 3) to risk-
stratify patients and suggest addition of the VA ECMO perfusion service, 
interventional cardiology/radiology, cardiothoracic service and an 
echocardiographer to the massive PE team in tertiary care centers where VA 
ECMO is a feasible option. We have found that the availability of this service at 
our institution has directly led to improved outcomes and excellent functional 
status at discharge.  
 
 
Figure 3: A proposed algorithm to manage massive or submassive 
pulmonary embolus  
 
 
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2015.17 Page 13 of 14 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
 
References 
1. Davies MJ, Arsiwala SS, Moore HM, Kerr S, Sosnowski AW, Firmin RK. 
Extracorporeal membrane oxygenation for the treatment of massive pulmonary 
embolism. Ann Thorac Surg.1995;60:1801–1803. 
 
2. Arlt M, Philipp A, Iesalnieks I, Kobuch R, Graf BM. Successful use of a new 
handheld ECMO system in cardiopulmonary failure and bleeding shock after 
thrombolysis in massive post-partial pulmonary embolism. Perfusion. 
2009;24:49–50. 
3. Cooley DA, Beall AC Jr, Alexander JK. Acute massive pulmonary embolism. 
Successful surgical treatment using temporary cardiopulmonary bypass. JAMA. 
1961;177:283–286. 
4. Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for 
massive pulmonary embolism. J Trauma. 2007;62:570–576. 
5. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach 
to the golden hour of hemodynamically significant pulmonary embolism. Chest. 
2002;121(3):877–905. 
6. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and 
submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic 
thromboembolic pulmonary hypertension: a scientific statement from the 
American Heart Association. Circulation. 2011;123:1788–1830. 
7. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. 
Antithrombotic therapy for venous thromboembolic disease American College of 
Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 
2008;133(6):454S–545S. 
8. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical 
outcomes in the International Cooperative Pulmonary Embolism Registry 
(ICOPER). The Lancet. 1999;353(9162):1386–1999. 
9. Schmitz-Rode T, Janssens U, Duda SH, Erley CM, Günther RW. Massive 
pulmonary embolism: percutaneous emergency treatment by pigtail rotation 
catheter. J Am Coll Cardiol. 2000;36:375–380. 
 
10. Fava M, Loyola S. Applications of percutaneous mechanical thrombectomy in 
pulmonary embolism. Tech Vasc Interv Radiol. 2003;6:53–58. 
 
11. Cho KJ, Dasika NL. Catheter technique for pulmonary embolectomy or 
thrombofragmentation. Semin Vasc Surg. 2000;13:221–235. 
 
 
 
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2015.17 Page 14 of 14 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
12. Kucher N, Windecker S, Banz Y, et al. Percutaneous catheter thrombectomy 
device for acute pulmonary embolism: in vitro and in vivo testing. Radiology. 
2005;236:852–858. 
 
13. Skaf E, Beenath A, Siddiqui T, Janua M, Patel NR, Stein PD. Catheter-tip 
embolectomy in the management of acute massive pulmonary embolism. Am J 
Cardiol. 2007;99:415-420. 
14. Stein PD, Alnas M, Beemath A, Patel NR. Outcome of pulmonary 
embolectomy. Am J Cardiol. 2007;99: 421–423.  
15. Leacche M, Unic D, Goldhaber SZ, et al. Modern surgical treatment of 
massive pulmonary embolism: results in 47 consecutive patients after rapid 
diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg. 
2005;129:1018–1023. 
16. Wood K. Major pulmonary embolism: review of a pathophysiologic approach 
to the golden hour of hemodynamically significant pulmonary embolism. Chest. 
2002;121:877–905. 
17. Ranucci M, Ballotta A, Kandil H, Isgro G, Carlucci C, Baryshnikova E, 
Pistuddi V. Bivalirudin-based versus conventional heparin anticoagulation for 
postcardiotomy extracorporeal membrane oxygenation. Critical Care 2011; 15: 
R275. 
